Tianjin TEDA Biomedical Engineering Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Li Sun
Chief executive officer
CN¥620.1k
Total compensation
| CEO salary percentage | 75.6% |
| CEO tenure | 9.5yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 8.3yrs |
Recent management updates
Recent updates
Some Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shareholders Look For Exit As Shares Take 29% Pounding
Apr 07
Subdued Growth No Barrier To Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) With Shares Advancing 55%
Jan 17Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Stock Rockets 38% As Investors Are Less Pessimistic Than Expected
Dec 02There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 73% Price Jump
Oct 17There's Reason For Concern Over Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) Massive 38% Price Jump
Aug 16Tianjin TEDA Biomedical Engineering Company Limited's (HKG:8189) 26% Share Price Plunge Could Signal Some Risk
May 07Is Tianjin TEDA Biomedical Engineering (HKG:8189) Weighed On By Its Debt Load?
Sep 12Investors Give Tianjin TEDA Biomedical Engineering Company Limited (HKG:8189) Shares A 28% Hiding
Apr 17Is Tianjin TEDA Biomedical Engineering (HKG:8189) A Risky Investment?
Apr 07Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?
Nov 01Tianjin TEDA Biomedical Engineering (HKG:8189) Is Making Moderate Use Of Debt
Apr 21Is Tianjin TEDA Biomedical Engineering (HKG:8189) Using Too Much Debt?
Oct 26Tianjin TEDA Biomedical Engineering (HKG:8189) Has Debt But No Earnings; Should You Worry?
Apr 06Health Check: How Prudently Does Tianjin TEDA Biomedical Engineering (HKG:8189) Use Debt?
Dec 22
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | n/a | n/a | -CN¥30m |
| Jun 30 2024 | n/a | n/a | -CN¥7m |
| Mar 31 2024 | n/a | n/a | -CN¥11m |
| Dec 31 2023 | CN¥620k | CN¥469k | -CN¥15m |
| Sep 30 2023 | n/a | n/a | -CN¥24m |
| Jun 30 2023 | n/a | n/a | -CN¥23m |
| Mar 31 2023 | n/a | n/a | -CN¥28m |
| Dec 31 2022 | CN¥709k | CN¥571k | -CN¥25m |
| Sep 30 2022 | n/a | n/a | -CN¥66m |
| Jun 30 2022 | n/a | n/a | -CN¥56m |
| Mar 31 2022 | n/a | n/a | -CN¥48m |
| Dec 31 2021 | CN¥749k | CN¥620k | -CN¥42m |
| Sep 30 2021 | n/a | n/a | -CN¥30m |
| Jun 30 2021 | n/a | n/a | -CN¥42m |
| Mar 31 2021 | n/a | n/a | -CN¥43m |
| Dec 31 2020 | CN¥698k | CN¥620k | -CN¥48m |
| Sep 30 2020 | n/a | n/a | -CN¥86m |
| Jun 30 2020 | n/a | n/a | -CN¥83m |
| Mar 31 2020 | n/a | n/a | -CN¥87m |
| Dec 31 2019 | CN¥728k | CN¥620k | -CN¥85m |
| Sep 30 2019 | n/a | n/a | -CN¥133m |
| Jun 30 2019 | n/a | n/a | -CN¥176m |
| Mar 31 2019 | n/a | n/a | -CN¥174m |
| Dec 31 2018 | CN¥709k | CN¥619k | -CN¥178m |
Compensation vs Market: Li's total compensation ($USD85.28K) is below average for companies of similar size in the Hong Kong market ($USD231.03K).
Compensation vs Earnings: Li's compensation has been consistent with company performance over the past year.
CEO
Li Sun (50 yo)
9.5yrs
Tenure
CN¥620,127
Compensation
Ms. Li Sun has been Chairman of the Board and Executive Director of Tianjin TEDA Biomedical Engineering Company Limited since August 20, 2015 and served as Chief Executive Officer since December 30, 2019 u...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 9.8yrs | CN¥620.13k | no data | |
| Non-Executive Director | 6.4yrs | no data | no data | |
| Chairman of the Supervisory Committee | 13.8yrs | CN¥124.27k | no data | |
| Independent Supervisor | 9.8yrs | no data | no data | |
| Non Executive Director | 8.3yrs | CN¥40.00k | no data | |
| Independent Non Executive Director | 8.3yrs | CN¥80.00k | no data | |
| Independent Non-Executive Director | 7.5yrs | CN¥80.00k | no data | |
| Non-Executive Director | 4yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
8.3yrs
Average Tenure
52.5yo
Average Age
Experienced Board: 8189's board of directors are considered experienced (8.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/02 15:06 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tianjin TEDA Biomedical Engineering Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.